Clinical Coordinating Center for the Network of Excellence in Neuroscience Clinical Trials (NEXT - CCC)

神经科学临床试验卓越网络临床协调中心 (NEXT - CCC)

基本信息

  • 批准号:
    10741962
  • 负责人:
  • 金额:
    $ 283.53万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-01 至 2028-08-31
  • 项目状态:
    未结题

项目摘要

Project Summary The long-term objective of the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT) initiative is to efficiently translate advances in neuroscience into treatments for adults and children with neurological disorders through partnerships with government, academia, private foundations, and industry. Recent discoveries in basic neuroscience have directly led to major breakthroughs in the understanding of disease processes in neurological disorders, many of which impose an enormous burden on individuals, families, and communities. Yet there are several organizational and logistical challenges to testing these new therapies in multicenter clinical trials, including inefficiencies in regulatory and institutional approvals, barriers to recruitment and retention of diverse study participants, and a dearth of individuals trained to be the leaders of multicenter clinical research trials. A central goal of NeuroNEXT (NN) is to facilitate, from initial conception through final analysis, high-quality early phase clinical trials and biomarker multisite studies with clear go/no-go decisions by providing efficient methodological, organizational, statistical, and logistical support. NeuroNEXT will also serve as the vehicle for the conduct of early clinical trials of gene therapy for ultra-rare neurological disorders. If warranted by the nature of the studied population, such as rare diseases, adaptive phase 2-3 trials and platform trials will be used. NeuroNEXT is comprised of 25 clinical sites, a Clinical Coordinating Center (CCC), and a Data Coordinating Center (DCC). Aim 1 is to create a collaborative and accessible CCC and clinical research network with the DCC, to efficiently conduct high-quality Phase 2 clinical trials, biomarker studies, and gene therapy trials in rare and common adult and pediatric neurological disorders. Aim 2 is to expand the pool and diversity of experienced clinical Investigators and research staff who are prepared to be leaders of multicenter clinical research trials. Aim 3 is to form strategic collaborations with key stakeholders in clinical trials, including government organizations, academia, foundations, industry partners, and patient-centered groups to organize high-impact clinical trials through NN for neurological disorders. NeuroNEXT innovations will include establishing a trial network that requires the use of a single institutional review board, a master contract process for all network- funded studies, centralized pharmacy and laboratory testing, a single Data Safety Monitoring Board for safety review, broad sharing of Standard Operating Procedures and knowledge, state-of-the-art early development trial design approaches, and the use of the common data elements for data collection. Applicants who seek to use the network can be novice or experienced trialists, thereby greatly expanding the pool and diversity of experienced clinical investigators trained and prepared to lead multicenter trials. New protocols will be proactively sought through several new outreach approaches. Eleven studies involving partnerships with industry, foundations, academia, and the government were funded in the first 11 years NN. The CCC will expand on these prior achievements to further advance and accelerate therapeutic development for neurological disorders.
项目总结

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Challenges and opportunities caring for neurology outpatients across language differences.
跨语言差异照顾神经科门诊患者的挑战和机遇。
  • DOI:
    10.1212/cpj.0000000000000634
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Tran,JessicaH;LuanErfe,BettyM;Kirwan,ChristopherJ;Mejia,NicteI
  • 通讯作者:
    Mejia,NicteI
Neurofilament light chain in a phase 2 clinical trial of ibudilast in progressive multiple sclerosis.
  • DOI:
    10.1177/1352458520986956
  • 发表时间:
    2021-11
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Fox RJ;Raska P;Barro C;Karafa M;Konig V;Bermel RA;Chase M;Coffey CS;Goodman AD;Klawiter EC;Naismith RT;Kuhle J
  • 通讯作者:
    Kuhle J
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MERIT E CUDKOWICZ其他文献

MERIT E CUDKOWICZ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MERIT E CUDKOWICZ', 18)}}的其他基金

Clinical Coordinating Center Network of Excellence in Neuroscience Clinical Trial
神经科学临床试验卓越临床协调中心网络
  • 批准号:
    10468050
  • 财政年份:
    2011
  • 资助金额:
    $ 283.53万
  • 项目类别:
Clinical Coordinating Center Network of Excellence in Neuroscience Clinical Trial
神经科学临床试验卓越临床协调中心网络
  • 批准号:
    8539105
  • 财政年份:
    2011
  • 资助金额:
    $ 283.53万
  • 项目类别:
Clinical Coordinating Center Network of Excellence in Neuroscience Clinical Trial
神经科学临床试验卓越临床协调中心网络
  • 批准号:
    10213840
  • 财政年份:
    2011
  • 资助金额:
    $ 283.53万
  • 项目类别:
Clinical Coordinating Center Network of Excellence in Neuroscience Clinical Trial
神经科学临床试验卓越临床协调中心网络
  • 批准号:
    8338822
  • 财政年份:
    2011
  • 资助金额:
    $ 283.53万
  • 项目类别:
Clinical Coordinating Center Network of Excellence in Neuroscience Clinical Trial
神经科学临床试验卓越临床协调中心网络
  • 批准号:
    8885926
  • 财政年份:
    2011
  • 资助金额:
    $ 283.53万
  • 项目类别:
Clinical Coordinating Center Network of Excellence in Neuroscience Clinical Trial
神经科学临床试验卓越临床协调中心网络
  • 批准号:
    9069323
  • 财政年份:
    2011
  • 资助金额:
    $ 283.53万
  • 项目类别:
Clinical Coordinating Center Network of Excellence in Neuroscience Clinical Trial
神经科学临床试验卓越临床协调中心网络
  • 批准号:
    10015348
  • 财政年份:
    2011
  • 资助金额:
    $ 283.53万
  • 项目类别:
Clinical Coordinating Center Network of Excellence in Neuroscience Clinical Trial
神经科学临床试验卓越临床协调中心网络
  • 批准号:
    9308007
  • 财政年份:
    2011
  • 资助金额:
    $ 283.53万
  • 项目类别:
Clinical Coordinating Center Network of Excellence in Neuroscience Clinical Trial
神经科学临床试验卓越临床协调中心网络
  • 批准号:
    8550171
  • 财政年份:
    2011
  • 资助金额:
    $ 283.53万
  • 项目类别:
Clinical Coordinating Center Network of Excellence in Neuroscience Clinical Trial
神经科学临床试验卓越临床协调中心网络
  • 批准号:
    8239805
  • 财政年份:
    2011
  • 资助金额:
    $ 283.53万
  • 项目类别:

相似海外基金

SHINE: Origin and Evolution of Compressible Fluctuations in the Solar Wind and Their Role in Solar Wind Heating and Acceleration
SHINE:太阳风可压缩脉动的起源和演化及其在太阳风加热和加速中的作用
  • 批准号:
    2400967
  • 财政年份:
    2024
  • 资助金额:
    $ 283.53万
  • 项目类别:
    Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
  • 批准号:
    2328975
  • 财政年份:
    2024
  • 资助金额:
    $ 283.53万
  • 项目类别:
    Continuing Grant
EXCESS: The role of excess topography and peak ground acceleration on earthquake-preconditioning of landslides
过量:过量地形和峰值地面加速度对滑坡地震预处理的作用
  • 批准号:
    NE/Y000080/1
  • 财政年份:
    2024
  • 资助金额:
    $ 283.53万
  • 项目类别:
    Research Grant
Market Entry Acceleration of the Murb Wind Turbine into Remote Telecoms Power
默布风力涡轮机加速进入远程电信电力市场
  • 批准号:
    10112700
  • 财政年份:
    2024
  • 资助金额:
    $ 283.53万
  • 项目类别:
    Collaborative R&D
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
  • 批准号:
    2328973
  • 财政年份:
    2024
  • 资助金额:
    $ 283.53万
  • 项目类别:
    Continuing Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
  • 批准号:
    2328972
  • 财政年份:
    2024
  • 资助金额:
    $ 283.53万
  • 项目类别:
    Continuing Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
  • 批准号:
    2332916
  • 财政年份:
    2024
  • 资助金额:
    $ 283.53万
  • 项目类别:
    Standard Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
  • 批准号:
    2332917
  • 财政年份:
    2024
  • 资助金额:
    $ 283.53万
  • 项目类别:
    Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
  • 批准号:
    2328974
  • 财政年份:
    2024
  • 资助金额:
    $ 283.53万
  • 项目类别:
    Continuing Grant
Radiation GRMHD with Non-Thermal Particle Acceleration: Next-Generation Models of Black Hole Accretion Flows and Jets
具有非热粒子加速的辐射 GRMHD:黑洞吸积流和喷流的下一代模型
  • 批准号:
    2307983
  • 财政年份:
    2023
  • 资助金额:
    $ 283.53万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了